The Pharmaceutical and Biotech industry activity utilizes metabolomics in a number of key areas in their drug research and development pipeline.
Pre-clinical use of cell lines, bioassays and animal models use metabolomics to validate target engagement, search for markers of disease progression and much more.
Clinical studies use retroactive / prospective samples from biorepositories or from on-going clinical studies with metabolomic profiles to help find early biomarkers of disease or understand patient stratification.
Click to see some representative publications or contact us to find out more.
[ PHARMACEUTICAL ]